News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) to Pay $3 Billion to Settle U.S. Government Probes


11/3/2011 6:53:34 AM

GlaxoSmithKline Plc has agreed in principle to settle its most significant disputes with the U.S. government over the way it marketed and developed its drugs, at a cost of $3 billion, which is covered by existing provisions. The settlement, over both civil and criminal claims, is expected to be finalised in 2012. It includes a Department of Justice investigation into the company's controversial diabetes drug Avandia, which has been linked to heart risks. Britain's biggest drugmaker already took massive charges last year related to liability claims from patients who had been taking Avandia.

Read at Reuters
Read at Wall Street Journal
Read at Philadelphia Inquirer
Read at SF Gate
Read at Washington Post
Read at Baltimore Sun

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES